Acute Myeloid Leukemia, Childhood

Search Trials
Familial Investigations of Childhood Cancer Predisposition
Status:
Recruiting
Last Changed:
May 13, 2022
First Changed:
Feb 10, 2017
Disease(s):
Acute Leukemia
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
Status:
Completed
Last Changed:
Sep 28, 2017
First Changed:
Mar 13, 2006
Disease(s):
Congenital Amegakaryocytic Thrombocytopenia
Intervention(s):
alemtuzumabbusulfancyclosporinefludarabine phosphatemethotrexatemethylprednisoloneallogeneic bone marrow transplantationallogeneic hematopoietic stem cell transplantationperipheral blood stem cell transplantationumbilical cord blood transplantation
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
Status:
Completed
Last Changed:
Nov 12, 2012
First Changed:
Mar 22, 2006
Disease(s):
Congenital Amegakaryocytic Thrombocytopenia
Intervention(s):
anti-thymocyte globulinbusulfanfludarabine phosphateallogeneic bone marrow transplantationperipheral blood stem cell transplantationumbilical cord blood transplantationradiation therapy
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Status:
Completed
Last Changed:
Jun 22, 2021
First Changed:
Mar 22, 2013
Disease(s):
Bacterial Infection
Intervention(s):
Chlorhexidine GluconateLaboratory Biomarker AnalysisQuestionnaire AdministrationWound Care Management

Connect. Empower. Inspire.